10.81

1.13% -0.18

Dentsply Sirona Inc (XRAY)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$10.99

Offen:

$10.89

24-Stunden-Volumen:

613.36K

Relative Volume:

0.12

Marktkapitalisierung:

$2.16B

Einnahmen:

$3.68B

Nettoeinkommen (Verlust:

$-627.00M

KGV:

-3.4343

EPS:

-3.1477

Netto-Cashflow:

$104.00M

1W Leistung:

-3.76%

1M Leistung:

-10.35%

6M Leistung:

-15.11%

1J Leistung:

-21.89%

1-Tages-Spanne:

$10.78

$10.94

1-Wochen-Bereich:

$10.78

$11.71

52-Wochen-Spanne:

$9.405

$14.76

Dentsply Sirona Inc Stock (XRAY) Company Profile

Firmenname

Dentsply Sirona Inc

Sektor

Healthcare (1087)

Branche

Medical Instruments & Supplies (56)

Telefon

844-546-3722

Adresse

13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC

Mitarbeiter

14,000

Twitter

@DentsplySirona

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

XRAY's Discussions on Twitter

Compare XRAY vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
XRAY Dentsply Sirona Inc	10.82	2.19B	3.68B	-627.00M	104.00M	-3.1477
ISRG Intuitive Surgical Inc	350.73	123.70B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	179.99	48.78B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	68.91	33.41B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	219.90	31.89B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	34.77	30.44B	29.14B	1.07B	1.05B	1.1956

Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Citigroup	Sell
2026-02-19	Hochstufung	BofA Securities	Neutral → Buy
2025-12-09	Eingeleitet	Barclays	Underweight
2025-11-07	Herabstufung	William Blair	Outperform → Mkt Perform
2025-04-15	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-03-13	Herabstufung	Needham	Buy → Hold
2025-02-14	Eingeleitet	Wells Fargo	Equal Weight
2025-01-23	Herabstufung	Jefferies	Buy → Hold
2025-01-07	Herabstufung	Evercore ISI	Outperform → In-line
2024-12-04	Eingeleitet	Mizuho	Neutral
2024-11-07	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-10-25	Bestätigt	Needham	Buy
2024-08-20	Bestätigt	Needham	Buy
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2023-11-16	Eingeleitet	Needham	Buy
2023-11-10	Hochstufung	William Blair	Mkt Perform → Outperform
2023-01-12	Hochstufung	William Blair	Underperform → Mkt Perform
2022-08-05	Herabstufung	William Blair	Mkt Perform → Underperform
2022-06-02	Hochstufung	UBS	Neutral → Buy
2022-04-20	Herabstufung	Piper Sandler	Overweight → Neutral
2022-04-20	Herabstufung	William Blair	Outperform → Mkt Perform
2022-04-19	Herabstufung	BofA Securities	Buy → Neutral
2022-04-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-01-31	Eingeleitet	Morgan Stanley	Overweight
2021-10-01	Fortgesetzt	Credit Suisse	Outperform
2021-08-09	Bestätigt	H.C. Wainwright	Neutral
2021-08-06	Bestätigt	Barrington Research	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-03-02	Hochstufung	Barrington Research	Mkt Perform → Outperform
2021-03-02	Bestätigt	H.C. Wainwright	Neutral
2021-01-05	Bestätigt	H.C. Wainwright	Neutral
2020-12-18	Herabstufung	Stifel	Buy → Hold
2020-11-17	Herabstufung	Barclays	Equal Weight → Underweight
2020-11-09	Bestätigt	H.C. Wainwright	Neutral
2020-10-22	Hochstufung	Guggenheim	Neutral → Buy
2020-08-10	Bestätigt	H.C. Wainwright	Neutral
2020-06-16	Eingeleitet	Piper Sandler	Overweight
2020-06-15	Bestätigt	H.C. Wainwright	Neutral
2020-05-27	Hochstufung	Evercore ISI	In-line → Outperform
2020-05-11	Herabstufung	Barrington Research	Outperform → Mkt Perform
2020-04-24	Bestätigt	H.C. Wainwright	Neutral
2020-04-08	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-04-07	Herabstufung	Goldman	Buy → Neutral
2020-04-02	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-03-03	Bestätigt	H.C. Wainwright	Neutral
2020-02-19	Bestätigt	Stifel	Buy
2019-12-11	Herabstufung	JP Morgan	Overweight → Neutral
2019-08-02	Hochstufung	Wellington Shields	Hold → Gradually Accumulate
2019-07-26	Eingeleitet	Evercore ISI	In-line
2019-07-09	Bestätigt	H.C. Wainwright	Neutral
2019-05-30	Eingeleitet	Wolfe Research	Peer Perform

Alle ansehen

Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten

Sep 08, 2026

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure - TradingView

Sep 08, 2026

Sep 07, 2026

Law firm investigates Dentsply Sirona officers for possible breaches of shareholder duties - Pluang

Sep 07, 2026

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire

Sep 07, 2026

Sep 05, 2026

Legal & General Group Plc Makes New $3.25 Million Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat

Sep 05, 2026

Sep 04, 2026

DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation - Yahoo Finance

Sep 04, 2026

Dentsply Sirona (XRAY) Stock May Still Trade At A Discount - Yahoo Finance

Sep 04, 2026

The Manufacturers Life Insurance Company Takes Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat

Sep 04, 2026

Does XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis? - Yahoo Finance

Sep 04, 2026

Sep 03, 2026

A live webcast will carry Dentsply Sirona’s Sept. 15 presentation - Stock Titan

Sep 03, 2026

Dentsply Sirona (XRAY) Swings Back To Profit While Sales Keep Sliding - Yahoo Finance

Sep 03, 2026

Sep 02, 2026

Is It Too Late to Buy Dentsply Sirona Inc (XRAY) After 4.8% Rall - GuruFocus

Sep 02, 2026

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Sep 02, 2026

Sep 01, 2026

Bank of New York Mellon Corp Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat

Sep 01, 2026

Aug 30, 2026

DENTSPLY SIRONA Inc (DY2) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks

Aug 30, 2026